User profiles for Joshua D. Ooi
Joshua D OoiMonash University Verified email at monash.edu Cited by 3819 |
Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells
JD Ooi, J Petersen, YH Tan, M Huynh, ZJ Willett… - Nature, 2017 - nature.com
Susceptibility and protection against human autoimmune diseases, including type I diabetes,
multiple sclerosis, and Goodpasture disease, is associated with particular human leukocyte …
multiple sclerosis, and Goodpasture disease, is associated with particular human leukocyte …
Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis
AJ Roth, JD Ooi, JJ Hess… - The Journal of …, 2013 - Am Soc Clin Investig
Anti-neutrophil cytoplasmic antibody–associated (ANCA-associated) small vessel necrotizing
vasculitis is caused by immune-mediated inflammation of the vessel wall and is diagnosed …
vasculitis is caused by immune-mediated inflammation of the vessel wall and is diagnosed …
Treg enhancing therapies to treat autoimmune diseases
PJ Eggenhuizen, BH Ng, JD Ooi - International journal of molecular …, 2020 - mdpi.com
Regulatory T cells (Tregs) are a small yet critical subset of CD4+ T cells, which have the role
of maintaining immune homeostasis by, for example, regulating self-tolerance, tumor …
of maintaining immune homeostasis by, for example, regulating self-tolerance, tumor …
The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis
Microscopic polyangiitis is an autoimmune small-vessel vasculitis that often manifests as
focal and necrotizing glomerulonephritis and renal failure. Antineutrophil cytoplasmic Abs (…
focal and necrotizing glomerulonephritis and renal failure. Antineutrophil cytoplasmic Abs (…
IL-23, not IL-12, directs autoimmunity to the Goodpasture antigen
JD Ooi, RKS Phoon, SR Holdsworth… - Journal of the American …, 2009 - journals.lww.com
The autoantigen in Goodpasture disease is the noncollagenous domain of α3 type IV
collagen [α3 (IV) NC1]. We previously demonstrated that IL-12p40−/− mice are protected from …
collagen [α3 (IV) NC1]. We previously demonstrated that IL-12p40−/− mice are protected from …
The NLRP3 inflammasome in kidney disease and autoimmunity
HL Hutton, JD Ooi, SR Holdsworth, AR Kitching - Nephrology, 2016 - Wiley Online Library
The NLRP3 inflammasome is an intracellular platform that converts the pro‐inflammatory
cytokines interleukin (IL)‐1β and IL‐18 to their active forms in response to ‘danger’ signals, …
cytokines interleukin (IL)‐1β and IL‐18 to their active forms in response to ‘danger’ signals, …
Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis
A major target autoantigen in anti-neutrophil cytoplasmic antibody–associated vasculitis is
myeloperoxidase (MPO). Although MPO-specific CD4+ Th cells seem to orchestrate renal …
myeloperoxidase (MPO). Although MPO-specific CD4+ Th cells seem to orchestrate renal …
Multiphoton imaging reveals a new leukocyte recruitment paradigm in the glomerulus
In contrast with many capillary beds, the glomerulus readily supports leukocyte recruitment.
However, little is known regarding the actions of leukocytes following their recruitment to …
However, little is known regarding the actions of leukocytes following their recruitment to …
The HLA-DRB1* 15: 01–restricted Goodpasture's T cell epitope induces GN
JD Ooi, J Chang, KM O'Sullivan… - Journal of the …, 2013 - journals.lww.com
Human anti-glomerular basement membrane (GBM) disease strongly associates with HLA-DRB1*
15: 01. The target autoantigen in this disease is the noncollagenous domain of the α3 …
15: 01. The target autoantigen in this disease is the noncollagenous domain of the α3 …
BCG vaccine derived peptides induce SARS-CoV-2 T cell cross-reactivity
Epidemiological studies and clinical trials suggest Bacillus Calmette-Guérin (BCG) vaccine
has protective effects against coronavirus disease 2019 (COVID-19). There are now over 30 …
has protective effects against coronavirus disease 2019 (COVID-19). There are now over 30 …